What Is at Stake in Genetic Newborn Screening for Rare Diseases? An Exploratory Qualitative Study of Parents' and Expectant Parents' Concerns in the Screen4Care Project

Martin S, Grauman Å, Coulter J, Hansson M, Ferlini A, Fortunato F, Ottombrino S, Raming R, Knieling F, Wachter F, Saier C, Freyler K, Veldwijk J (2026)

Publication Type: Journal article

Publication year: 2026

Book Volume: 29

Pages Range: 242-256

Journal Issue: 1

DOI: 10.1159/000553234

Abstract

INTRODUCTION: The diagnostic journey for rare diseases (RDs) often involves lengthy delays and significant burdens on patients and their families. Genetic newborn screening (NBS) for RDs offers a potential opportunity for early diagnosis and treatment. This study explores factors influencing parental decisions regarding participation in genetic NBS for RDs in two European countries (Italy and Germany). METHODS: This mixed-methods qualitative study is composed of focus group discussions and ranking exercises. It was conducted with parents seeking genetic testing (n = 5) and expectant parents from the general population (n = 11). All participants were recruited in spring 2024 in Germany and winter 2024 in Italy via contacts from genetic centres and obstetric services. Thematic analysis was performed by two independent coders to identify main themes and subthemes. RESULTS: Three key themes were identified: (1) the complexity of the decision-making process, (2) the importance of certainty and disease characteristics, and (3) the anticipation of negative consequences. Participants trusted healthcare professionals to guide their decisions, also emphasizing the need for extensive education and comprehensive support systems. Concerns about test accuracy, potential psychological impact of uncertain or positive results, and anticipated social implications were also reported. CONCLUSION: These findings highlight the nuanced considerations surrounding the implementation of genetic NBS for RDs and the necessity of addressing parental experiences in clinical practice and policy development. Participants emphasized the importance of accessible education and clear communication, the support of trusted healthcare professionals and that ethical reflection is essential for the equitable integration of genetic NBS into newborn care.

Authors with CRIS profile

Roman Raming Department of Paediatrics and Adolescent Medicine Ferdinand Knieling Department of Paediatrics and Adolescent Medicine Felix Wachter Department of Paediatrics and Adolescent Medicine

Involved external institutions

Ospedale Pediatrico Bambino Gesu IT Italy (IT) Universitätsklinikum Freiburg DE Germany (DE) Uppsala University SE Sweden (SE) Pfizer, Inc. US United States (USA) (US) Università degli Studi di Ferrara IT Italy (IT)

How to cite

APA:

Martin, S., Grauman, Å., Coulter, J., Hansson, M., Ferlini, A., Fortunato, F.,... Veldwijk, J. (2026). What Is at Stake in Genetic Newborn Screening for Rare Diseases? An Exploratory Qualitative Study of Parents' and Expectant Parents' Concerns in the Screen4Care Project. , 29(1), 242-256. https://doi.org/10.1159/000553234

MLA:

Martin, Sylvia, et al. "What Is at Stake in Genetic Newborn Screening for Rare Diseases? An Exploratory Qualitative Study of Parents' and Expectant Parents' Concerns in the Screen4Care Project." 29.1 (2026): 242-256.

BibTeX: Download